Doctor profile · Federal record
Dr. MALINI PATEL, M.D.
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · MAYWOOD, IL
- NPI 1619250461
- Accepts Medicare
- MIPS 88.9 / 100 · 2023
- 16 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2160 S 1ST AVE
MAYWOOD, IL 601533328
(708) 327-1249 - Mailing address
-
575 W MADISON ST, APT 3212
CHICAGO, IL 606612515
Credentials & registration
- NPI registered
- September 2011 — 15 yrs on file
- Profile last updated
- May 1, 2017
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Illinois #036135019
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1619250461. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
748
Distinct HCPCS
6
Medicare allowed
$103,356
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 511 | 122 | $137 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 77 | 67 | $134 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 77 | 42 | $84 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 39 | 31 | $193 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 30 | 30 | $237 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 14 | 12 | $121 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 88. This provider delivers 8.5× the peer median.Open Payments
Industry payments received
All-time total
$133
Transactions
8
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Gilead Sciences, Inc. | 2 | $34.37 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $33.47 | |
| AstraZeneca Pharmaceuticals LP | 1 | $18.83 | |
| Eisai Inc. | 1 | $17.02 | |
| PFIZER INC. | 1 | $16.31 | |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $13.08 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
475
Patients
96
Total drug cost
$915,989
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 75 | 23 | $3,048 |
| Acyclovir | Generic | 51 | 12 | $1,446 |
| Calquence (Acalabrutinib Maleate) | Brand | 40 | 0 | $570,108 |
| Dexamethasone | Generic | 40 | 15 | $433 |
| Levothyroxine Sodium | Generic | 35 | 0 | $408 |
| Ondansetron Hcl | Generic | 34 | 22 | $274 |
| Prochlorperazine Maleate | Generic | 31 | 24 | $425 |
| Letrozole | Generic | 28 | 0 | $630 |
| Hydroxyurea | Generic | 23 | 0 | $640 |
| Lenalidomide | Generic | 21 | 0 | $189,522 |